| Typicality: | 0.462 |
| Saliency: | 0.345 |
| with acquired resistance | 8 | other |
| with egfr-mutant lung cancer | 6 | other |
| currently | 2 | temporal |
| combination → be tested in → clinical trials | 10 |
| combination → be tested in → patient | 6 |
| negative | neutral | positive |
| 0.125 | 0.488 | 0.388 |
| Raw frequency | 16 |
| Normalized frequency | 0.345 |
| Modifier score | 0.700 |
| Perplexity | 58.743 |